Clinical Trial Update: Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg [NA]

View source ↗

Summary

A completed bioequivalence study comparing Tacrobell 1 mg to Prograf 1 mg in immunosuppression to determine if the two tacrolimus capsules are bioequivalent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosuppression

Drugs mentioned

• Prograf Capsule 1 mg (tacrolimus)
• Tacrobell Capsule 1 mg (tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Immunosuppression | NA | Status: COMPLETED